Marine natural products are a rich new seam of pharmaceutical chemistry; not only have natural products been the source of or the inspiration for over 75% of the new small-molecule chemical entities introduced as pharmaceuticals over the past 50 years, they remain a fundamental source of new chemical diversity and an integral component of modern science's pharmaceutical armoury. 

Aquapharm's core focus is the development of new pharmaceuticals from its marine microbial collection using its SeaRch™ technology to address areas of high unmet medical need, in particular Gram negative and Gram positive antibiotics.

Aquapharm's discovery portfolio also includes compounds that stimulate the natural oxidant defense mechanisms of human cells and novel anti-inflammatories.